Skip to main content

Table 2 Characteristics of the integrated data-base and FibroTest diagnostic value in liver disease

From: Meta-analyses of FibroTest diagnostic value in chronic liver disease

Disease

Number

Age yr

Biopsy Length mm

F0 (%)

F1 (%)

F2 (%)

F3 (%)

F4 (%)

ObAUROC

DANA

AdAUROC

High risk profile $ (%)

HCV

2,431

47

17

204 (8.4)

1123 (46.2)

531 (21.8)

298 (12.3)

275 (11.3)

0.77 0.75–0.79

1.92

0.83 0.81–0.85

26/1681 (1.5)

HBV

322

42

17

86 (26.7)

94 (29.2)

61 (18.9)

38 (11.8)

43 (11.4)

0.81 0.76–0.86

2.30

0.83 0.78–0.88

9/322 (2.8)

ALD

262

48

14

18 (6.9)

67 (25.6)

50 (19.1)

23 (8.8)

104 (39.7)

0.85 0.80–0.89*

2.52

0.85 0.80–0.89

5/262 (1.9)

NAFLD

267

51

19

102 (38.2)

94 (35.2)

35 (13.1)

23 (8.6)

13 (4.9)

0.81 0.74–0.86

2.21

0.84 0.77–0.89

7/267 (2.6)

All

3,282

47

17

410 (12.5)

1378 (42.0)

677 (20.6)

382 (11.6)

435 (13.3)

0.79 0.77–0.80

2.07

0.84 0.82–0.86

47/2,532 (1.9)

  1. * P = 0.001 between HCV and ALD for ObAUROC, Non Significant for AdAUROC